BRIEF-Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Reuters2026/09/30 22:33Standard BioTools Inc. LAB.O:
STANDARD BIOTOOLS PROVIDES UPDATE ON SALE OF MASS CYTOMETRY BUSINESS
STANDARD BIOTOOLS: TERMINATED ITS PREVIOUSLY ANNOUNCED AGREEMENT TO SELL ITS MASS CYTOMETRY BUSINESS TO MULTIPLEX BIO
STANDARD BIOTOOLS INC.: ENTERED DEFINITIVE AGREEMENT TO SELL ITS MASS CYTOMETRY BUSINESS TO ELEMENT BIOSYSTEMS FOR $5.5 MILLION IN CASH PAYABLE
Source text: ID:nGNX9NZtf1
Further company coverage: LAB.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - US auto parts company shares plunge after lowering 2027 revenue forecast
BUZZ-Heron Therapeutics shares surge due to CorMedix acquisition deal
Barclays increased its holdings of bitcoin ETF and MicroStrategy stock in the third quarter.
